目前已证实盐皮质激素受体拮抗剂（MRA）在射血分数降低的心力衰竭（HFrEF）中的疗效和安全性，研究显示其可显著降低患者的死亡率和再入院率。然而，由于高钾血症及与雄激素受体阻断相关的副作用，MRA的使用仍然不足。近期研究表明，非甾体类MRA在糖尿病和 ...

研究显示，停药1 年内，心血管死亡/心衰住院风险显著增加，停用RAS抑制剂/ARNI可导致心血管死亡/心衰住院风险增加38%，停用MRA可导致风险增加36%，但停用β受体阻滞剂 影响不大。 与LVEF ...

Patients who have been treated for heart failure and experience an improvement in their pump function are still at higher ...

A multicenter study by the PIOPED III Investigators has shown that magnetic resonance angiography (MRA) can be used to detect pulmonary embolism. The proportion of technically inadequate images ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

or MRA (mineralocorticoid receptor antagonists) had between 36 and 38 percent higher risk of heart-related death or hospitalisation within one year of medication discontinuation. However ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

an MRI or MRA provides detailed information about your aorta. Your surgeon will choose the best method for imaging your aorta. During this operation, the surgeon will make an incision, called a median ...